Armstrong announces ban on kratom, calls special legislative session - The Flag - AM 1100 and FM 92.3 WZFG
Armstrong has announced a ban on kratom, prompting a special legislative session to address the issue.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on September 2, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. All businesses involved in the sale or distribution of kratom, including independent pharmacies and retail chains. should confirm how it applies to their specific situation before acting. There is a time constraint attached: To be determined based on the legislative session outcomes.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
A ban on kratom has been proposed, which may affect its availability and legality for sale.
Who it affects
All businesses involved in the sale or distribution of kratom, including independent pharmacies and retail chains.
What you must do
Monitor the outcome of the legislative session and prepare to cease kratom sales if the ban is enacted.
Deadline
To be determined based on the legislative session outcomes.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- Major reforms to Alabama Board of Pharmacy narrowly pass committee - aldailynews.com
- What Does DEA’s Proposed Special Registration Framework for Tele-prescribing Controlled Substances Mean? - reedsmith.com
- Lawmakers want pharmacists involved with South Dakota's medical marijuana system - argusleader.com
- Pharmacy Board Bans Designer Drugs In Oregon - opb.org
- Fifth Circuit Stay Reinstates Nationwide In-Person Dispensing Requirement for Mifepristone - reedsmith.com